Non-Small Cell Carcinoma — Trials

Non-Small Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

6,756 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,752
Recruiting: 926
Ph III recruiting: 138
Growth YoY: +3.1%
Industry share: 44%
Top sponsor: AstraZeneca
Termination share: 38.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,045)

clinicaltrialsPublishedShowing 201–250 of 322 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04665206	Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors	recruiting	Phase 1 / Phase 2	434	Vivace Therapeutics, IncINDUSTRY	2	Apr 2, 2026	clinicaltrials
NCT06451497	This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors	recruiting	Phase 1	100	Zumutor Biologics Inc.INDUSTRY	1	Apr 2, 2026	clinicaltrials